{"transactions":[{"id":705132,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-21T22:31:46.000Z","date":"2026-07-17","kind":"grant","planned":false,"acquired":true,"shares":136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean July 17, 2026."}],"balance_after":136,"derivative":{"exercise_price":1.15,"expiration_date":"2036-07-17","underlying":"Common Stock","underlying_shares":136},"source":{"system":"sec-edgar","filing":"0001640334-26-001231","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033426001231/form4.xml","form_type":"4"}},{"id":705096,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29270,"kind":"person","name":"Blayney Douglas","position":1,"cik":"0001772396","reported_name":"Blayney Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-21T22:29:50.000Z","date":"2026-07-17","kind":"grant","planned":false,"acquired":true,"shares":136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean July 17, 2026."}],"balance_after":136,"derivative":{"exercise_price":1.15,"expiration_date":"2036-07-17","underlying":"Common Stock","underlying_shares":136},"source":{"system":"sec-edgar","filing":"0001640334-26-001229","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426001229/form4.xml","form_type":"4"}},{"id":705159,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29288,"kind":"person","name":"Reyes Gregory","position":1,"cik":"0001404055","reported_name":"Reyes Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-21T22:28:39.000Z","date":"2026-07-17","kind":"grant","planned":false,"acquired":true,"shares":136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean July 17, 2026."}],"balance_after":136,"derivative":{"exercise_price":1.15,"expiration_date":"2036-07-17","underlying":"Common Stock","underlying_shares":136},"source":{"system":"sec-edgar","filing":"0001640334-26-001227","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404055/000164033426001227/form4.xml","form_type":"4"}},{"id":705460,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29394,"kind":"person","name":"EMANUELE ROBERT MARTIN","position":1,"cik":"0001184991","reported_name":"EMANUELE ROBERT MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-21T22:27:11.000Z","date":"2026-07-17","kind":"grant","planned":true,"acquired":true,"shares":136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean July 17, 2026."}],"balance_after":136,"derivative":{"exercise_price":1.15,"expiration_date":"2036-07-17","underlying":"Common Stock","underlying_shares":136},"source":{"system":"sec-edgar","filing":"0001640334-26-001225","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184991/000164033426001225/form4.xml","form_type":"4"}},{"id":705111,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-21T22:25:46.000Z","date":"2026-07-17","kind":"grant","planned":false,"acquired":true,"shares":136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean July 17, 2026."}],"balance_after":136,"derivative":{"exercise_price":1.15,"expiration_date":"2036-07-17","underlying":"Common Stock","underlying_shares":136},"source":{"system":"sec-edgar","filing":"0001640334-26-001223","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033426001223/form4.xml","form_type":"4"}},{"id":705155,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-21T22:24:44.000Z","date":"2026-07-17","kind":"grant","planned":false,"acquired":true,"shares":136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean July 17, 2026."}],"balance_after":136,"derivative":{"exercise_price":1.15,"expiration_date":"2036-07-17","underlying":"Common Stock","underlying_shares":136},"source":{"system":"sec-edgar","filing":"0001640334-26-001221","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033426001221/form4.xml","form_type":"4"}},{"id":924726,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-02-02T21:57:43.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 30, 2026."}],"balance_after":292,"derivative":{"exercise_price":1.71,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":292},"source":{"system":"sec-edgar","filing":"0001640334-26-000199","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033426000199/form4.xml","form_type":"4"}},{"id":924488,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29270,"kind":"person","name":"Blayney Douglas","position":1,"cik":"0001772396","reported_name":"Blayney Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-02-02T21:53:50.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 30, 2026."}],"balance_after":292,"derivative":{"exercise_price":1.71,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":292},"source":{"system":"sec-edgar","filing":"0001640334-26-000198","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000198/form4.xml","form_type":"4"}},{"id":926457,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29394,"kind":"person","name":"EMANUELE ROBERT MARTIN","position":1,"cik":"0001184991","reported_name":"EMANUELE ROBERT MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-02-02T21:50:53.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 30, 2026."}],"balance_after":292,"derivative":{"exercise_price":1.71,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":292},"source":{"system":"sec-edgar","filing":"0001640334-26-000197","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184991/000164033426000197/form4.xml","form_type":"4"}},{"id":924608,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-02-02T21:48:20.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 30, 2026."}],"balance_after":292,"derivative":{"exercise_price":1.71,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":292},"source":{"system":"sec-edgar","filing":"0001640334-26-000196","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033426000196/form4.xml","form_type":"4"}},{"id":924750,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-02-02T21:45:34.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 30, 2026."}],"balance_after":292,"derivative":{"exercise_price":1.71,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":292},"source":{"system":"sec-edgar","filing":"0001640334-26-000195","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033426000195/form4.xml","form_type":"4"}},{"id":924774,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29288,"kind":"person","name":"Reyes Gregory","position":1,"cik":"0001404055","reported_name":"Reyes Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-02-02T21:41:56.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 30, 2026."}],"balance_after":292,"derivative":{"exercise_price":1.71,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":292},"source":{"system":"sec-edgar","filing":"0001640334-26-000194","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404055/000164033426000194/form4.xml","form_type":"4"}},{"id":924486,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":68167,"kind":"person","name":"Spring Mark Edward","position":1,"cik":"0002091857","reported_name":"Spring Mark Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2026-02-02T21:38:04.000Z","date":"2026-01-29","kind":"grant","planned":false,"acquired":true,"shares":36391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date, such that the option shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 1, 2026."}],"balance_after":36391,"derivative":{"exercise_price":1.68,"expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":36391},"source":{"system":"sec-edgar","filing":"0001640334-26-000193","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000193/form4.xml","form_type":"4"}},{"id":924566,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":68179,"kind":"person","name":"Gorgas Gregory D.","position":1,"cik":"0001526251","reported_name":"Gorgas Gregory D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, CEO, CFO, Treas & Secr"}}],"security":"Stock Options (right to buy)","published_at":"2026-02-02T16:34:05.000Z","date":"2026-01-29","kind":"grant","planned":false,"acquired":true,"shares":154713,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date, such that the option shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 1, 2026."}],"balance_after":154713,"derivative":{"exercise_price":1.68,"expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":154713},"source":{"system":"sec-edgar","filing":"0001640334-26-000192","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1526251/000164033426000192/form4.xml","form_type":"4"}},{"id":1011250,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-10-31T01:30:05.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":true,"price":110843,"reported_value":110843,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."}],"derivative":{"exercise_price":3.4,"exercise_date":"2025-10-28","expiration_date":"2026-04-28","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001640334-25-001925","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033425001925/form4.xml","form_type":"4"}},{"id":1011249,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-10-31T01:30:05.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":true,"shares":70376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."}],"balance_after":70376,"derivative":{"exercise_price":3.4,"exercise_date":"2025-10-28","expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":70376},"source":{"system":"sec-edgar","filing":"0001640334-25-001925","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033425001925/form4.xml","form_type":"4"}},{"id":1011248,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-10-31T01:30:05.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":true,"shares":38346,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."}],"balance_after":38346,"derivative":{"exercise_price":6.24,"exercise_date":"2025-10-28","expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":38346},"source":{"system":"sec-edgar","filing":"0001640334-25-001925","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033425001925/form4.xml","form_type":"4"}},{"id":1011247,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-10-31T01:30:05.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":false,"price":140000,"reported_value":140000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."}],"derivative":{"exercise_date":"2025-05-01","expiration_date":"2025-10-28","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001640334-25-001925","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033425001925/form4.xml","form_type":"4"}},{"id":1011256,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-10-31T01:28:31.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":true,"price":19793,"reported_value":19793,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."}],"derivative":{"exercise_price":3.4,"exercise_date":"2025-10-28","expiration_date":"2026-04-28","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001640334-25-001923","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033425001923/form4.xml","form_type":"4"}},{"id":1011255,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-10-31T01:28:31.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":true,"shares":12566,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."}],"balance_after":12566,"derivative":{"exercise_price":3.4,"exercise_date":"2025-10-28","expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":12566},"source":{"system":"sec-edgar","filing":"0001640334-25-001923","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033425001923/form4.xml","form_type":"4"}},{"id":1011254,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-10-31T01:28:31.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":true,"shares":6846,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."}],"balance_after":6846,"derivative":{"exercise_price":6.24,"exercise_date":"2025-10-28","expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":6846},"source":{"system":"sec-edgar","filing":"0001640334-25-001923","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033425001923/form4.xml","form_type":"4"}},{"id":1011253,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-10-31T01:28:31.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":false,"price":25000,"reported_value":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."}],"derivative":{"exercise_date":"2025-05-01","expiration_date":"2025-10-28","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001640334-25-001923","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033425001923/form4.xml","form_type":"4"}},{"id":1011205,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":68179,"kind":"person","name":"Gorgas Gregory D.","position":1,"cik":"0001526251","reported_name":"Gorgas Gregory D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, Treasurer, Sec"}}],"security":"Convertible Promissory Note","published_at":"2025-10-30T21:27:37.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":true,"price":27710,"reported_value":27710,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"underlyingValue","element":"underlyingSecurityValue","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"underlyingValue","element":"underlyingSecurityValue","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."}],"derivative":{"exercise_price":3.4,"exercise_date":"2025-10-28","expiration_date":"2026-04-28","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001640334-25-001921","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1526251/000164033425001921/form4.xml","form_type":"4"}},{"id":1011204,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":68179,"kind":"person","name":"Gorgas Gregory D.","position":1,"cik":"0001526251","reported_name":"Gorgas Gregory D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, Treasurer, Sec"}}],"security":"Warrant (right to buy)","published_at":"2025-10-30T21:27:37.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":true,"shares":17952,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."}],"balance_after":17952,"derivative":{"exercise_price":3.4,"exercise_date":"2025-10-28","expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":17952},"source":{"system":"sec-edgar","filing":"0001640334-25-001921","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1526251/000164033425001921/form4.xml","form_type":"4"}},{"id":1011203,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":68179,"kind":"person","name":"Gorgas Gregory D.","position":1,"cik":"0001526251","reported_name":"Gorgas Gregory D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, Treasurer, Sec"}}],"security":"Warrant (right to buy)","published_at":"2025-10-30T21:27:37.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":true,"shares":9586,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."}],"balance_after":9586,"derivative":{"exercise_price":6.24,"exercise_date":"2025-10-28","expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":9586},"source":{"system":"sec-edgar","filing":"0001640334-25-001921","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1526251/000164033425001921/form4.xml","form_type":"4"}},{"id":1011202,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":68179,"kind":"person","name":"Gorgas Gregory D.","position":1,"cik":"0001526251","reported_name":"Gorgas Gregory D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, Treasurer, Sec"}}],"security":"Convertible Promissory Note","published_at":"2025-10-30T21:27:37.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":false,"price":35000,"reported_value":35000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the \"May Note\"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock (\"Common Stock\") (the \"$6.24 Warrant\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On October 28, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the \"October Note\"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the \"$3.40 Warrant\"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock."}],"derivative":{"exercise_date":"2025-05-01","expiration_date":"2025-10-28","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001640334-25-001921","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1526251/000164033425001921/form4.xml","form_type":"4"}},{"id":1091132,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":68179,"kind":"person","name":"Gorgas Gregory D.","position":1,"cik":"0001526251","reported_name":"Gorgas Gregory D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, CFO, Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2025-07-07T16:40:52.000Z","date":"2025-07-02","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(2) Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, fifty percent (50%) of the shares subject to the option shall vest January 1, 2026 and the remaining fifty percent (50%) of the shares subject to the option shall vest January 1, 2027."}],"balance_after":20000,"derivative":{"exercise_price":11.03,"expiration_date":"2035-07-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001640334-25-001136","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1526251/000164033425001136/primary_doc.xml","form_type":"4"}},{"id":1091131,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":68179,"kind":"person","name":"Gorgas Gregory D.","position":1,"cik":"0001526251","reported_name":"Gorgas Gregory D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, CFO, Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2025-07-07T16:40:52.000Z","date":"2025-07-02","kind":"grant","planned":false,"acquired":true,"shares":20393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"(1) Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date, such that the option shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. Vesting Commencement Date shall mean January 1, 2025."}],"balance_after":20393,"derivative":{"exercise_price":11.03,"expiration_date":"2035-07-02","underlying":"Common Stock","underlying_shares":20393},"source":{"system":"sec-edgar","filing":"0001640334-25-001136","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1526251/000164033425001136/primary_doc.xml","form_type":"4"}},{"id":1158956,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-05-05T21:24:07.000Z","date":"2025-05-01","kind":"purchase","planned":false,"acquired":true,"price":25000,"reported_value":25000,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On or about May 1, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") with the Reporting Person, pursuant to which the Issuer issued a convertible note (the \"Note\") to the Reporting Person. The Notes will accrue interest at a rate of 12% per annum, which will adjust to 20% upon an Event of Default (as defined in the Note). All unpaid principal, together with any then unpaid and accrued interest and other amounts payable thereunder, shall be due and payable on October 28, 2025 (the \"Maturity Date\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"At the Maturity Date, the Reporting Person may (at the Reporting Person's sole option) convert all of that certain unpaid portion of principal and accrued interest of the Reporting Person's Note into shares of the Issuer's common stock (\"Common Stock\") (the \"Voluntary Conversion\"), specifically into that number of shares of Common Stock (the \"Converted Shares\") equal to the unpaid principal balance and any accrued interest of each Note divided by $1.29. The amount of principal balance and any accrued interest of the Note convertible pursuant to the Voluntary Conversion shall be the number of Converted Shares multiplied by $1.04 (the \"Minimum Price\"). Should the Reporting Person not elect Voluntary Conversion, such portion of the unpaid principal balance and any accrued interest of the Note subject to Voluntary Conversion shall be immediately due and payable in cash."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"At the Maturity Date, that portion of the unpaid principal balance and any accrued interest of the Note not subject to the Voluntary Conversion shall be automatically converted into a warrant to purchase shares of the Issuer's Common Stock (the \"Warrant\") at a conversion price of $0.125 per share issuable pursuant to the Warrant (the \"Automatic Conversion\"). The exercise price of such Warrant for each Warrant Share shall be equal to the Minimum Price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On or about May 1, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") with the Reporting Person, pursuant to which the Issuer issued a convertible note (the \"Note\") to the Reporting Person. The Notes will accrue interest at a rate of 12% per annum, which will adjust to 20% upon an Event of Default (as defined in the Note). All unpaid principal, together with any then unpaid and accrued interest and other amounts payable thereunder, shall be due and payable on October 28, 2025 (the \"Maturity Date\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"At the Maturity Date, the Reporting Person may (at the Reporting Person's sole option) convert all of that certain unpaid portion of principal and accrued interest of the Reporting Person's Note into shares of the Issuer's common stock (\"Common Stock\") (the \"Voluntary Conversion\"), specifically into that number of shares of Common Stock (the \"Converted Shares\") equal to the unpaid principal balance and any accrued interest of each Note divided by $1.29. The amount of principal balance and any accrued interest of the Note convertible pursuant to the Voluntary Conversion shall be the number of Converted Shares multiplied by $1.04 (the \"Minimum Price\"). Should the Reporting Person not elect Voluntary Conversion, such portion of the unpaid principal balance and any accrued interest of the Note subject to Voluntary Conversion shall be immediately due and payable in cash."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"At the Maturity Date, that portion of the unpaid principal balance and any accrued interest of the Note not subject to the Voluntary Conversion shall be automatically converted into a warrant to purchase shares of the Issuer's Common Stock (the \"Warrant\") at a conversion price of $0.125 per share issuable pursuant to the Warrant (the \"Automatic Conversion\"). The exercise price of such Warrant for each Warrant Share shall be equal to the Minimum Price."}],"derivative":{"exercise_date":"2025-05-01","expiration_date":"2025-10-28","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001640334-25-000789","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033425000789/form4.xml","form_type":"4"}},{"id":1158891,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-05-05T21:21:52.000Z","date":"2025-05-01","kind":"purchase","planned":false,"acquired":true,"price":140000,"reported_value":140000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On or about May 1, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") with the Reporting Person, pursuant to which the Issuer issued a convertible note (the \"Note\") to the Reporting Person. The Notes will accrue interest at a rate of 12% per annum, which will adjust to 20% upon an Event of Default (as defined in the Note). All unpaid principal, together with any then unpaid and accrued interest and other amounts payable thereunder, shall be due and payable on October 28, 2025 (the \"Maturity Date\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"At the Maturity Date, the Reporting Person may (at the Reporting Person's sole option) convert all of that certain unpaid portion of principal and accrued interest of the Reporting Person's Note into shares of the Issuer's common stock (\"Common Stock\") (the \"Voluntary Conversion\"), specifically into that number of shares of Common Stock (the \"Converted Shares\") equal to the unpaid principal balance and any accrued interest of each Note divided by $1.29. The amount of principal balance and any accrued interest of the Note convertible pursuant to the Voluntary Conversion shall be the number of Converted Shares multiplied by $1.04 (the \"Minimum Price\"). Should the Reporting Person not elect Voluntary Conversion, such portion of the unpaid principal balance and any accrued interest of the Note subject to Voluntary Conversion shall be immediately due and payable in cash."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"At the Maturity Date, that portion of the unpaid principal balance and any accrued interest of the Note not subject to the Voluntary Conversion shall be automatically converted into a warrant to purchase shares of the Issuer's Common Stock (the \"Warrant\") at a conversion price of $0.125 per share issuable pursuant to the Warrant (the \"Automatic Conversion\"). The exercise price of such Warrant for each Warrant Share shall be equal to the Minimum Price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On or about May 1, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") with the Reporting Person, pursuant to which the Issuer issued a convertible note (the \"Note\") to the Reporting Person. The Notes will accrue interest at a rate of 12% per annum, which will adjust to 20% upon an Event of Default (as defined in the Note). All unpaid principal, together with any then unpaid and accrued interest and other amounts payable thereunder, shall be due and payable on October 28, 2025 (the \"Maturity Date\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"At the Maturity Date, the Reporting Person may (at the Reporting Person's sole option) convert all of that certain unpaid portion of principal and accrued interest of the Reporting Person's Note into shares of the Issuer's common stock (\"Common Stock\") (the \"Voluntary Conversion\"), specifically into that number of shares of Common Stock (the \"Converted Shares\") equal to the unpaid principal balance and any accrued interest of each Note divided by $1.29. The amount of principal balance and any accrued interest of the Note convertible pursuant to the Voluntary Conversion shall be the number of Converted Shares multiplied by $1.04 (the \"Minimum Price\"). Should the Reporting Person not elect Voluntary Conversion, such portion of the unpaid principal balance and any accrued interest of the Note subject to Voluntary Conversion shall be immediately due and payable in cash."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"At the Maturity Date, that portion of the unpaid principal balance and any accrued interest of the Note not subject to the Voluntary Conversion shall be automatically converted into a warrant to purchase shares of the Issuer's Common Stock (the \"Warrant\") at a conversion price of $0.125 per share issuable pursuant to the Warrant (the \"Automatic Conversion\"). The exercise price of such Warrant for each Warrant Share shall be equal to the Minimum Price."}],"derivative":{"exercise_date":"2025-05-01","expiration_date":"2025-10-28","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001640334-25-000788","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033425000788/form4.xml","form_type":"4"}},{"id":1158754,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":68179,"kind":"person","name":"Gorgas Gregory D.","position":1,"cik":"0001526251","reported_name":"Gorgas Gregory D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, CEO, CFO, Treas & Secr"}}],"security":"Convertible Promissory Note","published_at":"2025-05-05T17:21:39.000Z","date":"2025-05-01","kind":"purchase","planned":false,"acquired":true,"price":35000,"reported_value":35000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On or about May 1, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") with the Reporting Person, pursuant to which the Issuer issued a convertible note (the \"Note\") to the Reporting Person. The Notes will accrue interest at a rate of 12% per annum, which will adjust to 20% upon an Event of Default (as defined in the Note). All unpaid principal, together with any then unpaid and accrued interest and other amounts payable thereunder, shall be due and payable on October 28, 2025 (the \"Maturity Date\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"At the Maturity Date, the Reporting Person may (at the Reporting Person's sole option) convert all of that certain unpaid portion of principal and accrued interest of the Reporting Person's Note into shares of the Issuer's common stock (\"Common Stock\") (the \"Voluntary Conversion\"), specifically into that number of shares of Common Stock (the \"Converted Shares\") equal to the unpaid principal balance and any accrued interest of each Note divided by $1.29. The amount of principal balance and any accrued interest of the Note convertible pursuant to the Voluntary Conversion shall be the number of Converted Shares multiplied by $1.04 (the \"Minimum Price\"). Should the Reporting Person not elect Voluntary Conversion, such portion of the unpaid principal balance and any accrued interest of the Note subject to Voluntary Conversion shall be immediately due and payable in cash."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"At the Maturity Date, that portion of the unpaid principal balance and any accrued interest of the Note not subject to the Voluntary Conversion shall be automatically converted into a warrant to purchase shares of the Issuer's Common Stock (the \"Warrant\") at a conversion price of $0.125 per share issuable pursuant to the Warrant (the \"Automatic Conversion\"). The exercise price of such Warrant for each Warrant Share shall be equal to the Minimum Price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On or about May 1, 2025, the Issuer entered into a Subscription Agreement (the \"Subscription Agreement\") with the Reporting Person, pursuant to which the Issuer issued a convertible note (the \"Note\") to the Reporting Person. The Notes will accrue interest at a rate of 12% per annum, which will adjust to 20% upon an Event of Default (as defined in the Note). All unpaid principal, together with any then unpaid and accrued interest and other amounts payable thereunder, shall be due and payable on October 28, 2025 (the \"Maturity Date\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"At the Maturity Date, the Reporting Person may (at the Reporting Person's sole option) convert all of that certain unpaid portion of principal and accrued interest of the Reporting Person's Note into shares of the Issuer's common stock (\"Common Stock\") (the \"Voluntary Conversion\"), specifically into that number of shares of Common Stock (the \"Converted Shares\") equal to the unpaid principal balance and any accrued interest of each Note divided by $1.29. The amount of principal balance and any accrued interest of the Note convertible pursuant to the Voluntary Conversion shall be the number of Converted Shares multiplied by $1.04 (the \"Minimum Price\"). Should the Reporting Person not elect Voluntary Conversion, such portion of the unpaid principal balance and any accrued interest of the Note subject to Voluntary Conversion shall be immediately due and payable in cash."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"At the Maturity Date, that portion of the unpaid principal balance and any accrued interest of the Note not subject to the Voluntary Conversion shall be automatically converted into a warrant to purchase shares of the Issuer's Common Stock (the \"Warrant\") at a conversion price of $0.125 per share issuable pursuant to the Warrant (the \"Automatic Conversion\"). The exercise price of such Warrant for each Warrant Share shall be equal to the Minimum Price."}],"derivative":{"exercise_date":"2025-05-01","expiration_date":"2025-10-28","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001640334-25-000787","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1526251/000164033425000787/form4.xml","form_type":"4"}},{"id":1322732,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-23T21:02:27.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean December 20, 2024."}],"balance_after":1750,"derivative":{"exercise_price":0.9476,"expiration_date":"2034-12-20","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001640334-24-001935","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033424001935/form4.xml","form_type":"4"}},{"id":1322583,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29270,"kind":"person","name":"Blayney Douglas","position":1,"cik":"0001772396","reported_name":"Blayney Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-23T21:02:08.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean December 20, 2024."}],"balance_after":1750,"derivative":{"exercise_price":0.9476,"expiration_date":"2034-12-20","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001640334-24-001933","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033424001933/form4.xml","form_type":"4"}},{"id":1322751,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29288,"kind":"person","name":"Reyes Gregory","position":1,"cik":"0001404055","reported_name":"Reyes Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-23T21:01:49.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean December 20, 2024."}],"balance_after":1750,"derivative":{"exercise_price":0.9476,"expiration_date":"2034-12-20","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001640334-24-001931","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404055/000164033424001931/form4.xml","form_type":"4"}},{"id":1323665,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29394,"kind":"person","name":"EMANUELE ROBERT MARTIN","position":1,"cik":"0001184991","reported_name":"EMANUELE ROBERT MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-23T21:01:31.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean December 20, 2024."}],"balance_after":1750,"derivative":{"exercise_price":0.9476,"expiration_date":"2034-12-20","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001640334-24-001929","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184991/000164033424001929/form4.xml","form_type":"4"}},{"id":1322677,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-23T21:01:12.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean December 20, 2024."}],"balance_after":1750,"derivative":{"exercise_price":0.9476,"expiration_date":"2034-12-20","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001640334-24-001927","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424001927/form4.xml","form_type":"4"}},{"id":1322745,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-23T21:00:49.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean December 20, 2024."}],"balance_after":1750,"derivative":{"exercise_price":0.9476,"expiration_date":"2034-12-20","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001640334-24-001925","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424001925/form4.xml","form_type":"4"}},{"id":1606710,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":1083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":1083,"derivative":{"exercise_price":1.55,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1606709,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1606708,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1606707,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1606706,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":2000,"derivative":{"exercise_price":1.55,"expiration_date":"2031-03-05","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1606705,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean August 4, 2023."}],"balance_after":0,"derivative":{"exercise_price":2.01,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1606704,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean June 30, 2023."}],"balance_after":0,"derivative":{"exercise_price":1.99,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1606703,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":4.89,"exercise_date":"2023-06-24","expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1606702,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2022-06-23","expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1606701,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29284,"kind":"person","name":"FAVORITO TAMARA A","position":1,"cik":"0001288232","reported_name":"FAVORITO TAMARA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:53:09.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was granted on March 5, 2021 and was previously reported as covering 30,000 shares at an exercise price of $1.52 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan (the \"Plan\")) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, one third (1/3rd) of the shares subject to the option shall vest on the two (2) year anniversary of the Vesting Commencement Date, one third (1/3rd) of the shares subject to the option shall vest on the three (3) year anniversary of the Vesting Commencement Date, such that the option shall be fully vested on the three (3) year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean March 5, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on March 5, 2021 and was previously reported as covering 30,000 shares at an exercise price of $1.52 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":22.8,"expiration_date":"2031-03-05","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001640334-24-000335","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288232/000164033424000335/primary_doc.xml","form_type":"4"}},{"id":1609092,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29394,"kind":"person","name":"EMANUELE ROBERT MARTIN","position":1,"cik":"0001184991","reported_name":"EMANUELE ROBERT MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:08:19.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":1083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":1083,"derivative":{"exercise_price":1.55,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-24-000334","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1184991/000164033424000334/primary_doc.xml","form_type":"4"}},{"id":1609091,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29394,"kind":"person","name":"EMANUELE ROBERT MARTIN","position":1,"cik":"0001184991","reported_name":"EMANUELE ROBERT MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:08:19.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000334","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1184991/000164033424000334/primary_doc.xml","form_type":"4"}},{"id":1609090,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29394,"kind":"person","name":"EMANUELE ROBERT MARTIN","position":1,"cik":"0001184991","reported_name":"EMANUELE ROBERT MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:08:19.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000334","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1184991/000164033424000334/primary_doc.xml","form_type":"4"}},{"id":1609089,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29394,"kind":"person","name":"EMANUELE ROBERT MARTIN","position":1,"cik":"0001184991","reported_name":"EMANUELE ROBERT MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:08:19.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000334","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1184991/000164033424000334/primary_doc.xml","form_type":"4"}},{"id":1609088,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29394,"kind":"person","name":"EMANUELE ROBERT MARTIN","position":1,"cik":"0001184991","reported_name":"EMANUELE ROBERT MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:08:19.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":8034,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":8034,"derivative":{"exercise_price":1.55,"expiration_date":"2031-02-12","underlying":"Common Stock","underlying_shares":8034},"source":{"system":"sec-edgar","filing":"0001640334-24-000334","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1184991/000164033424000334/primary_doc.xml","form_type":"4"}},{"id":1609087,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29394,"kind":"person","name":"EMANUELE ROBERT MARTIN","position":1,"cik":"0001184991","reported_name":"EMANUELE ROBERT MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:08:19.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":1167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":1167,"derivative":{"exercise_price":1.55,"expiration_date":"2029-08-29","underlying":"Common Stock","underlying_shares":1167},"source":{"system":"sec-edgar","filing":"0001640334-24-000334","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1184991/000164033424000334/primary_doc.xml","form_type":"4"}},{"id":1609086,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29394,"kind":"person","name":"EMANUELE ROBERT MARTIN","position":1,"cik":"0001184991","reported_name":"EMANUELE ROBERT MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:08:19.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":834,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":834,"derivative":{"exercise_price":1.55,"expiration_date":"2028-08-17","underlying":"Common Stock","underlying_shares":834},"source":{"system":"sec-edgar","filing":"0001640334-24-000334","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1184991/000164033424000334/primary_doc.xml","form_type":"4"}},{"id":1609085,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29394,"kind":"person","name":"EMANUELE ROBERT MARTIN","position":1,"cik":"0001184991","reported_name":"EMANUELE ROBERT MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:08:19.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean August 4, 2023."}],"balance_after":0,"derivative":{"exercise_price":2.01,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-24-000334","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1184991/000164033424000334/primary_doc.xml","form_type":"4"}},{"id":1609084,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29394,"kind":"person","name":"EMANUELE ROBERT MARTIN","position":1,"cik":"0001184991","reported_name":"EMANUELE ROBERT MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:08:19.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan (the \"Plan\")) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean June 30, 2023."}],"balance_after":0,"derivative":{"exercise_price":1.99,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000334","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1184991/000164033424000334/primary_doc.xml","form_type":"4"}},{"id":1609083,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29394,"kind":"person","name":"EMANUELE ROBERT MARTIN","position":1,"cik":"0001184991","reported_name":"EMANUELE ROBERT MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:08:19.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":4.89,"exercise_date":"2023-06-24","expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000334","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1184991/000164033424000334/primary_doc.xml","form_type":"4"}},{"id":1609082,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29394,"kind":"person","name":"EMANUELE ROBERT MARTIN","position":1,"cik":"0001184991","reported_name":"EMANUELE ROBERT MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:08:19.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2022-06-23","expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000334","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1184991/000164033424000334/primary_doc.xml","form_type":"4"}},{"id":1609081,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29394,"kind":"person","name":"EMANUELE ROBERT MARTIN","position":1,"cik":"0001184991","reported_name":"EMANUELE ROBERT MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:08:19.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8034,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This option was granted on February 12, 2021 and was previously reported as covering 120,500 shares at an exercise price of $2.66 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"This option was granted on February 12, 2021 and was previously reported as covering 120,500 shares at an exercise price of $2.66 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":39.9,"exercise_date":"2023-02-12","expiration_date":"2031-02-12","underlying":"Common Stock","underlying_shares":8034},"source":{"system":"sec-edgar","filing":"0001640334-24-000334","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1184991/000164033424000334/primary_doc.xml","form_type":"4"}},{"id":1609080,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29394,"kind":"person","name":"EMANUELE ROBERT MARTIN","position":1,"cik":"0001184991","reported_name":"EMANUELE ROBERT MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:08:19.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1167,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This option was granted on August 29, 2019 and was previously reported as covering 17,500 shares at an exercise price of $1.99 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"This option was granted on August 29, 2019 and was previously reported as covering 17,500 shares at an exercise price of $1.99 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":29.85,"exercise_date":"2020-02-29","expiration_date":"2029-08-29","underlying":"Common Stock","underlying_shares":1167},"source":{"system":"sec-edgar","filing":"0001640334-24-000334","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1184991/000164033424000334/primary_doc.xml","form_type":"4"}},{"id":1609079,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29394,"kind":"person","name":"EMANUELE ROBERT MARTIN","position":1,"cik":"0001184991","reported_name":"EMANUELE ROBERT MARTIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:08:19.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":834,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was granted on August 17, 2018 and was previously reported as covering 12,500 shares at an exercise price of $10.80 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on August 17, 2018 and was previously reported as covering 12,500 shares at an exercise price of $10.80 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":162,"exercise_date":"2021-08-17","expiration_date":"2028-08-17","underlying":"Common Stock","underlying_shares":834},"source":{"system":"sec-edgar","filing":"0001640334-24-000334","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184991/000164033424000334/primary_doc.xml","form_type":"4"}},{"id":1606482,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":1083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":1083,"derivative":{"exercise_price":1.55,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606481,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606480,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606479,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606478,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":9634,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":9634,"derivative":{"exercise_price":1.55,"expiration_date":"2031-02-12","underlying":"Common Stock","underlying_shares":9634},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606477,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":1484,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":1484,"derivative":{"exercise_price":1.55,"expiration_date":"2029-08-29","underlying":"Common Stock","underlying_shares":1484},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606476,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean August 4, 2023."}],"balance_after":0,"derivative":{"exercise_price":2.01,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606475,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan (the \"Plan\")) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean June 30, 2023."}],"balance_after":0,"derivative":{"exercise_price":1.99,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606474,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":4.89,"exercise_date":"2023-06-24","expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606473,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2022-06-23","expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606472,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9634,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This option was granted on February 12, 2021 and was previously reported as covering 144,500 shares at an exercise price of $2.66 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"This option was granted on February 12, 2021 and was previously reported as covering 144,500 shares at an exercise price of $2.66 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":39.9,"exercise_date":"2023-02-12","expiration_date":"2031-02-12","underlying":"Common Stock","underlying_shares":9634},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606471,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1484,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was granted on August 29, 2019 and was previously reported as covering 22,250 shares at an exercise price of $1.99 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on August 29, 2019 and was previously reported as covering 22,250 shares at an exercise price of $1.99 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":29.85,"exercise_date":"2020-02-29","expiration_date":"2029-08-29","underlying":"Common Stock","underlying_shares":1484},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606743,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29288,"kind":"person","name":"Reyes Gregory","position":1,"cik":"0001404055","reported_name":"Reyes Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T00:08:15.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":1083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":1083,"derivative":{"exercise_price":1.55,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-24-000331","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1404055/000164033424000331/primary_doc.xml","form_type":"4"}},{"id":1606742,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29288,"kind":"person","name":"Reyes Gregory","position":1,"cik":"0001404055","reported_name":"Reyes Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T00:08:15.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000331","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1404055/000164033424000331/primary_doc.xml","form_type":"4"}},{"id":1606741,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29288,"kind":"person","name":"Reyes Gregory","position":1,"cik":"0001404055","reported_name":"Reyes Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T00:08:15.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000331","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1404055/000164033424000331/primary_doc.xml","form_type":"4"}},{"id":1606740,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29288,"kind":"person","name":"Reyes Gregory","position":1,"cik":"0001404055","reported_name":"Reyes Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T00:08:15.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000331","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1404055/000164033424000331/primary_doc.xml","form_type":"4"}},{"id":1606739,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29288,"kind":"person","name":"Reyes Gregory","position":1,"cik":"0001404055","reported_name":"Reyes Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T00:08:15.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":8000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":8000,"derivative":{"exercise_price":1.55,"expiration_date":"2030-12-04","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001640334-24-000331","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1404055/000164033424000331/primary_doc.xml","form_type":"4"}},{"id":1606738,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29288,"kind":"person","name":"Reyes Gregory","position":1,"cik":"0001404055","reported_name":"Reyes Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T00:08:15.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean August 4, 2023."}],"balance_after":0,"derivative":{"exercise_price":2.01,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-24-000331","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1404055/000164033424000331/primary_doc.xml","form_type":"4"}},{"id":1606737,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29288,"kind":"person","name":"Reyes Gregory","position":1,"cik":"0001404055","reported_name":"Reyes Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T00:08:15.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean June 30, 2023."}],"balance_after":0,"derivative":{"exercise_price":1.99,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000331","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1404055/000164033424000331/primary_doc.xml","form_type":"4"}},{"id":1606736,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29288,"kind":"person","name":"Reyes Gregory","position":1,"cik":"0001404055","reported_name":"Reyes Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T00:08:15.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":4.89,"exercise_date":"2023-06-24","expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000331","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404055/000164033424000331/primary_doc.xml","form_type":"4"}},{"id":1606735,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29288,"kind":"person","name":"Reyes Gregory","position":1,"cik":"0001404055","reported_name":"Reyes Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T00:08:15.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2022-06-23","expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000331","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404055/000164033424000331/primary_doc.xml","form_type":"4"}},{"id":1606734,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29288,"kind":"person","name":"Reyes Gregory","position":1,"cik":"0001404055","reported_name":"Reyes Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T00:08:15.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was granted on December 4, 2020 and was previously reported as covering 120,000 shares at an exercise price of $0.6035 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan (the \"Plan\")) through such applicable vesting date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean December 4, 2020."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on December 4, 2020 and was previously reported as covering 120,000 shares at an exercise price of $0.6035 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":9.05,"expiration_date":"2030-12-04","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001640334-24-000331","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404055/000164033424000331/primary_doc.xml","form_type":"4"}},{"id":1606052,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29270,"kind":"person","name":"Blayney Douglas","position":1,"cik":"0001772396","reported_name":"Blayney Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:17.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":1083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":1083,"derivative":{"exercise_price":1.55,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-24-000330","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033424000330/primary_doc.xml","form_type":"4"}},{"id":1606051,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29270,"kind":"person","name":"Blayney Douglas","position":1,"cik":"0001772396","reported_name":"Blayney Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:17.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000330","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033424000330/primary_doc.xml","form_type":"4"}},{"id":1606050,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29270,"kind":"person","name":"Blayney Douglas","position":1,"cik":"0001772396","reported_name":"Blayney Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:17.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000330","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033424000330/primary_doc.xml","form_type":"4"}},{"id":1606049,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29270,"kind":"person","name":"Blayney Douglas","position":1,"cik":"0001772396","reported_name":"Blayney Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:17.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000330","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033424000330/primary_doc.xml","form_type":"4"}},{"id":1606048,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29270,"kind":"person","name":"Blayney Douglas","position":1,"cik":"0001772396","reported_name":"Blayney Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:17.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":9300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":9300,"derivative":{"exercise_price":1.55,"expiration_date":"2031-02-12","underlying":"Common Stock","underlying_shares":9300},"source":{"system":"sec-edgar","filing":"0001640334-24-000330","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033424000330/primary_doc.xml","form_type":"4"}},{"id":1606047,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29270,"kind":"person","name":"Blayney Douglas","position":1,"cik":"0001772396","reported_name":"Blayney Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:17.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":1200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":1200,"derivative":{"exercise_price":1.55,"expiration_date":"2029-08-29","underlying":"Common Stock","underlying_shares":1200},"source":{"system":"sec-edgar","filing":"0001640334-24-000330","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033424000330/primary_doc.xml","form_type":"4"}},{"id":1606046,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29270,"kind":"person","name":"Blayney Douglas","position":1,"cik":"0001772396","reported_name":"Blayney Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:17.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean August 4, 2023."}],"balance_after":0,"derivative":{"exercise_price":2.01,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-24-000330","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033424000330/primary_doc.xml","form_type":"4"}},{"id":1606045,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29270,"kind":"person","name":"Blayney Douglas","position":1,"cik":"0001772396","reported_name":"Blayney Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:17.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan (the \"Plan\")) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean June 30, 2023."}],"balance_after":0,"derivative":{"exercise_price":1.99,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000330","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033424000330/primary_doc.xml","form_type":"4"}},{"id":1606044,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29270,"kind":"person","name":"Blayney Douglas","position":1,"cik":"0001772396","reported_name":"Blayney Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:17.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":4.89,"exercise_date":"2023-06-24","expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000330","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033424000330/primary_doc.xml","form_type":"4"}},{"id":1606043,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29270,"kind":"person","name":"Blayney Douglas","position":1,"cik":"0001772396","reported_name":"Blayney Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:17.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2022-06-23","expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000330","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033424000330/primary_doc.xml","form_type":"4"}},{"id":1606042,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29270,"kind":"person","name":"Blayney Douglas","position":1,"cik":"0001772396","reported_name":"Blayney Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:17.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9300,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This option was granted on February 12, 2021 and was previously reported as covering 139,500 shares at an exercise price of $2.66 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"This option was granted on February 12, 2021 and was previously reported as covering 139,500 shares at an exercise price of $2.66 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":39.9,"exercise_date":"2023-02-12","expiration_date":"2031-02-12","underlying":"Common Stock","underlying_shares":9300},"source":{"system":"sec-edgar","filing":"0001640334-24-000330","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033424000330/primary_doc.xml","form_type":"4"}},{"id":1606041,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29270,"kind":"person","name":"Blayney Douglas","position":1,"cik":"0001772396","reported_name":"Blayney Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:17.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1200,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was granted on August 29, 2019 and was previously reported as covering 18,000 shares at an exercise price of $1.99 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on August 29, 2019 and was previously reported as covering 18,000 shares at an exercise price of $1.99 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":29.85,"exercise_date":"2020-02-29","expiration_date":"2029-08-29","underlying":"Common Stock","underlying_shares":1200},"source":{"system":"sec-edgar","filing":"0001640334-24-000330","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033424000330/primary_doc.xml","form_type":"4"}},{"id":1606657,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:12.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":1083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":1083,"derivative":{"exercise_price":1.55,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-24-000329","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033424000329/primary_doc.xml","form_type":"4"}},{"id":1606656,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:12.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000329","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033424000329/primary_doc.xml","form_type":"4"}},{"id":1606655,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:12.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000329","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033424000329/primary_doc.xml","form_type":"4"}},{"id":1606654,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:12.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000329","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033424000329/primary_doc.xml","form_type":"4"}},{"id":1606653,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29281,"kind":"person","name":"MATSUI CONNIE","position":1,"cik":"0001236537","reported_name":"MATSUI CONNIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T23:09:12.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":10634,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":10634,"derivative":{"exercise_price":1.55,"expiration_date":"2031-02-12","underlying":"Common Stock","underlying_shares":10634},"source":{"system":"sec-edgar","filing":"0001640334-24-000329","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1236537/000164033424000329/primary_doc.xml","form_type":"4"}}],"next_cursor":"2024-03-01T23:09:12.000000Z,1606653"}